These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12393537)

  • 1. Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria.
    Murakami Y; Kosaka H; Maeda Y; Nishimura J; Inoue N; Ohishi K; Okabe M; Takeda J; Kinoshita T
    Blood; 2002 Dec; 100(12):4116-22. PubMed ID: 12393537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Noji H
    Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.
    van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H
    Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of paroxysmal nocturnal hemoglobinuria.
    Inoue N; Murakami Y; Kinoshita T
    Int J Hematol; 2003 Feb; 77(2):107-12. PubMed ID: 12627844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
    Shichishima T
    Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria.
    Kawagoe K; Kitamura D; Okabe M; Taniuchi I; Ikawa M; Watanabe T; Kinoshita T; Takeda J
    Blood; 1996 May; 87(9):3600-6. PubMed ID: 8611683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Tiu R; Maciejewski J
    Int J Hematol; 2006 Aug; 84(2):113-7. PubMed ID: 16926131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxysmal nocturnal hemoglobinuria with copy number-neutral 6pLOH in GPI (+) but not in GPI (-) granulocytes.
    Ueda Y; Nishimura J; Murakami Y; Kajigaya S; Kinoshita T; Kanakura Y; Young NS
    Eur J Haematol; 2014; 92(5):450-3. PubMed ID: 24931618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations and clonal expansions in paroxysmal nocturnal hemoglobinuria.
    Hosokawa K; Nakao S
    Semin Hematol; 2022 Jul; 59(3):143-149. PubMed ID: 36115691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.
    Pakdeesuwan K; Muangsup W; Pratya YU; Issaragrisil S; Wanachiwanawin W
    Int J Hematol; 2001 Jan; 73(1):64-70. PubMed ID: 11372757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Boccuni P; Del Vecchio L; Di Noto R; Rotoli B
    Crit Rev Oncol Hematol; 2000 Jan; 33(1):25-43. PubMed ID: 10714960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria.
    Gargiulo L; Papaioannou M; Sica M; Talini G; Chaidos A; Richichi B; Nikolaev AV; Nativi C; Layton M; de la Fuente J; Roberts I; Luzzatto L; Notaro R; Karadimitris A
    Blood; 2013 Apr; 121(14):2753-61. PubMed ID: 23372165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different roles of glycosylphosphatidylinositol in various hematopoietic cells as revealed by a mouse model of paroxysmal nocturnal hemoglobinuria.
    Murakami Y; Kinoshita T; Maeda Y; Nakano T; Kosaka H; Takeda J
    Blood; 1999 Nov; 94(9):2963-70. PubMed ID: 10556178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of selective expansion of PNH clones.
    Nakakuma H; Kawaguchi T
    Int J Hematol; 2003 Feb; 77(2):121-4. PubMed ID: 12627846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes.
    Ware RE; Pickens CV; DeCastro CM; Howard TA
    Exp Hematol; 2001 Dec; 29(12):1403-9. PubMed ID: 11750098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights Into the Emergence of Paroxysmal Nocturnal Hemoglobinuria.
    Colden MA; Kumar S; Munkhbileg B; Babushok DV
    Front Immunol; 2021; 12():830172. PubMed ID: 35154088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuria.
    Gargiulo L; Lastraioli S; Cerruti G; Serra M; Loiacono F; Zupo S; Luzzatto L; Notaro R
    Blood; 2007 Jun; 109(11):5036-42. PubMed ID: 17284529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of T Lymphocytes in the Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria.
    Li C; Dong X; Wang H; Shao Z
    Front Immunol; 2021; 12():777649. PubMed ID: 35003092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria.
    Tseng JE; Hall SE; Howard TA; Ware RE
    Am J Hematol; 1995 Dec; 50(4):244-53. PubMed ID: 7485098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glycosylphosphatidylinositol anchor and paroxysmal nocturnal haemoglobinuria/aplasia model.
    Hall C; Richards SJ; Hillmen P
    Acta Haematol; 2002; 108(4):219-30. PubMed ID: 12432218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.